Organization | Sathbhavana Brain Clinic

Sathbhavana Brain Clinic Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2005

NCT01955655

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2005

Timeline

NOW

Now

Alternative names

Sathbhavana Brain Clinic | Sathbhavana Brain Clinic, Hyderabad, India | Sathbhavana Brain Clinic, Secunderabad, India

Active Ingredients

Drugs in Phase 4 Trials (9)

amitriptyline (elavil) (1 trial)

baclofen (lioresal) (2 trials)

clonazepam (klonopin) (1 trial)

diazepam (valium) (1 trial)

gabapentin (neurontin) (1 trial)

lamotrigine (lamictal) (1 trial)

tetrabenazine (xenazine) (1 trial)

topiramate (topamax) (1 trial)

trihexyphenidyl (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Cerebral Palsy (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 9